Hill International (HIL) Reaches $5.10 After 3.00% Down Move; Last Week Repros Therapeutics (RPRX) Analysts

November 3, 2017 - By Richard Conner

Among 3 analysts covering Repros Therapeutics (NASDAQ:RPRX), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Repros Therapeutics had 5 analyst reports since August 20, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, November 16 by Ladenburg Thalmann. Zacks upgraded the shares of RPRX in report on Thursday, August 20 to “Hold” rating. The firm earned “Underperform” rating on Friday, October 30 by Bank of America. On Friday, October 30 the stock rating was downgraded by Brean Capital to “Hold”. On Friday, October 30 the stock rating was downgraded by Ladenburg Thalmann to “Neutral”. See Repros Therapeutics Inc (NASDAQ:RPRX) latest ratings:

The stock of Hill International Inc (NYSE:HIL) is a huge mover today! The stock decreased 3.77% or $0.2 during the last trading session, reaching $5.1. About 73,696 shares traded. Hill International Inc (NYSE:HIL) has risen 22.81% since November 3, 2016 and is uptrending. It has outperformed by 6.11% the S&P500.The move comes after 9 months negative chart setup for the $264.58 million company. It was reported on Nov, 3 by Barchart.com. We have $4.95 PT which if reached, will make NYSE:HIL worth $7.94 million less.

Hill International, Inc. is a professional services firm. The company has market cap of $264.58 million. The Firm provides program management, project management, construction management and other consulting services primarily to the buildings, transportation, environmental, energy and industrial markets worldwide. It currently has negative earnings. It operates in Project Management Group segment.

Since May 11, 2017, it had 2 buys, and 4 sales for $506,992 activity. Shares for $102,379 were bought by Sgro David. Richter Irvin E sold $360,800 worth of Hill International Inc (NYSE:HIL) on Thursday, May 11. The insider Andrews Camille S sold 22,727 shares worth $104,544. On Monday, May 22 Fellheimer Alan S sold $111,362 worth of Hill International Inc (NYSE:HIL) or 22,727 shares. Clymer Brian W sold $104,544 worth of Hill International Inc (NYSE:HIL) on Tuesday, May 16.

Investors sentiment decreased to 0.73 in 2017 Q2. Its down 0.52, from 1.25 in 2017Q1. It dived, as 6 investors sold Hill International Inc shares while 24 reduced holdings. 8 funds opened positions while 14 raised stakes. 23.51 million shares or 2.87% less from 24.20 million shares in 2017Q1 were reported. Sg Americas Securities Ltd Liability Company invested 0% in Hill International Inc (NYSE:HIL). Financial Bank Of Mellon, a New York-based fund reported 116,058 shares. Goldman Sachs Grp reported 10,355 shares or 0% of all its holdings. Manufacturers Life Ins The has invested 0% in Hill International Inc (NYSE:HIL). Rutabaga Capital Mgmt Lc Ma holds 1.70 million shares. Prelude Cap Management Ltd Limited Liability Company accumulated 0.04% or 85,462 shares. Tci Wealth Advsr accumulated 0% or 437 shares. Ny State Common Retirement Fund reported 16,700 shares stake. Bulldog holds 4.32% in Hill International Inc (NYSE:HIL) or 3.27M shares. Foundry Prtn Limited Liability Co stated it has 555,630 shares or 0.12% of all its holdings. Fisher Asset Management Ltd Liability Company has 0% invested in Hill International Inc (NYSE:HIL) for 25,336 shares. Panagora Asset Management reported 0% in Hill International Inc (NYSE:HIL). Deutsche Savings Bank Ag holds 0% in Hill International Inc (NYSE:HIL) or 37,289 shares. Art Advisors Limited reported 0.01% of its portfolio in Hill International Inc (NYSE:HIL). Dimensional Fund Advsr Ltd Partnership has invested 0.01% of its portfolio in Hill International Inc (NYSE:HIL).

About 439,572 shares traded. Repros Therapeutics Inc (NASDAQ:RPRX) has declined 73.82% since November 3, 2016 and is downtrending. It has underperformed by 90.52% the S&P500.

Investors sentiment decreased to 0.22 in 2017 Q2. Its down 0.87, from 1.09 in 2017Q1. It turned negative, as 6 investors sold Repros Therapeutics Inc shares while 12 reduced holdings. 2 funds opened positions while 2 raised stakes. 5.05 million shares or 15.39% less from 5.97 million shares in 2017Q1 were reported. Savings Bank Of Montreal Can stated it has 0% of its portfolio in Repros Therapeutics Inc (NASDAQ:RPRX). Baldwin Brothers Ma holds 0% or 1,750 shares in its portfolio. Retail Bank Of America Corp De reported 56,087 shares. 6,400 are held by Wells Fargo & Mn. Manufacturers Life Insurance The reported 0% stake. Creative Planning holds 0% or 5,000 shares. 76,187 were accumulated by Northern Trust. Hudson Bay Cap Mngmt Limited Partnership has invested 0% in Repros Therapeutics Inc (NASDAQ:RPRX). Morgan Stanley holds 3,792 shares or 0% of its portfolio. Geode Capital Mngmt Ltd Limited Liability Company holds 131,112 shares. Goldman Sachs Group Incorporated has 0% invested in Repros Therapeutics Inc (NASDAQ:RPRX) for 13,107 shares. Northwestern Mutual Wealth owns 25 shares. Renaissance Techs Ltd Liability Corp reported 956,013 shares stake. Benjamin F Edwards And Inc reported 0% in Repros Therapeutics Inc (NASDAQ:RPRX). Blackrock holds 685,127 shares.